Smith BioMed is a renowned brand that specializes in medical diagnostics and point-of-care testing. Founded in 2002, the company initially focused on the production of rapid on-site disposable tests for detecting drugs of abuse in urine and saliva. By implementing these tests, the efficacy of workplace screening has significantly improved, resulting in enhanced employee health and safety.

Moreover, the productivity of various industries has experienced remarkable advancements. Building upon this success, Smith BioMed has expanded into the field of point-of-care medical diagnostics, capitalizing on the similarities between medical disposable devices and their drug and alcohol testing counterparts. The brand is known for its early diagnosis capabilities, convenience, and cost-effectiveness, making it a leader in the industry.

Smith BioMed stays at the forefront of global pharmaceutical research and developments in manufacturing organizations, allowing them to offer cutting-edge technologies and rapid on-site forensic screening for drugs of abuse. With a team of experts, including John Spurway, Executive Director, and Elizabeth Plant, Clinical Consultant, Smith BioMed is committed to developing meaningful technologies that improve the lives of individuals in Australia and New Zealand. Contact them via info@smithbiomed.

com for more information